Atlas Trials

Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary Hyperparathyroidism

Clinical trial NCT03226171 · COMPLETED

Trial details

NCT number
NCT03226171
Sponsor
Sanwa Kagaku Kenkyusho Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Secondary Hyperparathyroidism
Start date
2017-06-20
Primary completion
2018-09-11
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.